Pain reports · 2025
Clinical characterization of neuropathic pain and small fiber impairment in neurofibromatosis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Meller Eva, Amann Annsophie, Malik Rayaz A, Kampik Daniel, Matthies Cordula, Üçeyler Nurcan
Аннотация
INTRODUCTION: Pain is an often underestimated symptom in patients with neurofibromatosis (NF) and schwannomatosis (SWN), yet it may have a profound impact on health-related quality of life.
OBJECTIVE: To assess the characteristics of neuropathic pain and small nerve fiber impairment in patients with NF.
METHODS: In this case-control study, we enrolled 51 patients who fulfilled the diagnostic criteria for neurofibromatosis type 1 (NF1), NF2-related schwannomatosis (SWN-NF2), and schwannomatosis-not otherwise specified (SWN-NOS). Patients completed validated questionnaires for pain and health-related quality of life and underwent neurological examination, nerve conduction studies, nerve sonography, quantitative sensory testing (QST), distal and proximal skin-punch biopsy, and corneal confocal microscopy (CCM).
RESULTS: Pain was reported by 28 of 51 (55%) patients with 18 of 51 (35%) suffering from neuropathic pain. Pain was chronic (≥3 months) in all patients with neuropathic pain. In 28 of 51 (55%) patients, skin biopsies revealed signs of denervation, while 7 of 51 (14%) patients exhibited ≥2 pathological small fiber tests and were classified as having small fiber impairment.
CONCLUSION: Neuropathic pain and small fiber abnormalities are prevalent among patients with NF as well as SWN. Although no clear correlation between small fiber damage and painful neuropathy was found, these findings need special attention and correct categorization to offer efficient analgesic treatment.
OBJECTIVE: To assess the characteristics of neuropathic pain and small nerve fiber impairment in patients with NF.
METHODS: In this case-control study, we enrolled 51 patients who fulfilled the diagnostic criteria for neurofibromatosis type 1 (NF1), NF2-related schwannomatosis (SWN-NF2), and schwannomatosis-not otherwise specified (SWN-NOS). Patients completed validated questionnaires for pain and health-related quality of life and underwent neurological examination, nerve conduction studies, nerve sonography, quantitative sensory testing (QST), distal and proximal skin-punch biopsy, and corneal confocal microscopy (CCM).
RESULTS: Pain was reported by 28 of 51 (55%) patients with 18 of 51 (35%) suffering from neuropathic pain. Pain was chronic (≥3 months) in all patients with neuropathic pain. In 28 of 51 (55%) patients, skin biopsies revealed signs of denervation, while 7 of 51 (14%) patients exhibited ≥2 pathological small fiber tests and were classified as having small fiber impairment.
CONCLUSION: Neuropathic pain and small fiber abnormalities are prevalent among patients with NF as well as SWN. Although no clear correlation between small fiber damage and painful neuropathy was found, these findings need special attention and correct categorization to offer efficient analgesic treatment.